What is NDC 24338-018?

24338-018 is the product NDC for Myhibbin (mycophenolate mofetil), Mycophenolate mofetil 200 mg/mL suspension, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Myhibbin (Mycophenolate mofetil).

Azurity Pharmaceuticals, Inc., NDC labeler code 24338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Myhibbin?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Myhibbin NDC 24338-018 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)24338-018Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24338-0018Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24338-018-01	2433800180124338001801	1 BOTTLE, PLASTIC in 1 CARTON (24338-018-01) / 175 mL in 1 BOTTLE, PLASTICMarketed from Jun 10, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Myhibbin
Generic name (nonproprietary): mycophenolate mofetil
Active ingredients: Mycophenolate mofetil — 200 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc.NDC labeler code 24338
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 216482
Marketing start: Jun 10, 2024
Listing expires: Dec 31, 2027
Identifiers: Product ID 24338-018_4a03cc1d-8a3d-4b41-a8df-2772a513bd61SPL ID 4a03cc1d-8a3d-4b41-a8df-2772a513bd61
Pharmacologic class: Antimetabolite Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424338001801 followed by a unit qualifier and the quantity

Package 24338-0018-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 24338-018

What is NDC 24338-018?: 24338-018 is the product NDC for Myhibbin (mycophenolate mofetil), Mycophenolate mofetil 200 mg/mL suspension, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Myhibbin (Mycophenolate mofetil).
What is the active ingredient?: Mycophenolate mofetil.
Who is the labeler?: Azurity Pharmaceuticals, Inc., NDC labeler code 24338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Myhibbin?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Myhibbin (Mycophenolate mofetil) NDC 24338-018